Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

33.00
BATS BZX Real-Time Price
As of 1:20pm ET
 +0.09 / +0.27%
Today’s Change
17.61
Today|||52-Week Range
35.40
+51.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$4.1B

Company Description

Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and prescription pharmaceuticals, as well as, animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The Consumer Health segment engages in the sales of animal health and over-the-counter products, both branded and private label. The company was founded in 1971 and is headquartered in Lake Forest, IL.

Contact Information

Akorn, Inc.
1925 West Field Court
Lake Forest Illinois 60045-4862
P:(847) 279-6100
Investor Relations:

Employees

Shareholders

Mutual fund holders39.09%
Other institutional35.44%
Individual stakeholders30.11%

Top Executives

Rajat RaiChief Executive Officer
Bruce KutinskyChief Operating Officer
Duane A. PortwoodCFO & Executive Vice President
Mark M. SilverbergExecutive VP-Operations & Technical Services
Joseph P. BonaccorsiSecretary, Senior Vice President & General Counsel